• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Morgan Stanley - Product Image

Morgan Stanley

  • ID: 621644
  • March 2015
  • 39 Pages
  • Wright Investors Service

A textual analysis of the financial results for Morgan Stanley compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Morgan Stanley. There is a textual review of the financial results of Morgan Stanley versus Goldman Sachs Group Inc, Intl Fcstone Inc and Is Yatirim Menkul Degerler A.S. The comparative analysis of these companies compares Sales (sales, sales growth and sales per READ MORE >

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

United States

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Compagnie Financiere Tradition - Product Thumbnail Image

    Compagnie Financiere Tradition

    • Language: English
    • 38 Pages
    • Published: February 2015
    FROM
  • Turkiye Sinai Kalkinma Bankasi A.S. - Product Thumbnail Image

    Turkiye Sinai Kalkinma Bankasi A.S.

    • Language: English
    • 39 Pages
    • Published: February 2015
    FROM
  • Is Yatirim Menkul Degerler A.S. - Product Thumbnail Image

    Is Yatirim Menkul Degerler A.S.

    • Language: English
    • 38 Pages
    • Published: February 2015
    FROM
  • Natixis - Product Thumbnail Image

    Natixis

    • Language: English
    • 39 Pages
    • Published: March 2015
    FROM
  • Nomura Holdings Incorporated - Product Thumbnail Image

    Nomura Holdings Incorporated

    • Language: English
    • 38 Pages
    • Published: March 2015
    FROM
  • Goldman Sachs Group Inc - Product Thumbnail Image

    Goldman Sachs Group Inc

    • Language: English
    • 39 Pages
    • Published: March 2015
    FROM
  • Intl Fcstone Inc - Product Thumbnail Image

    Intl Fcstone Inc

    • Language: English
    • 35 Pages
    • Published: March 2015
    FROM
  • Hutchison Whampoa Limited - Product Thumbnail Image

    Hutchison Whampoa Limited

    • Language: English
    • 39 Pages
    • Published: March 2015
    FROM
  • Gedik Yatirim Menkul Degerler AS - Product Thumbnail Image

    Gedik Yatirim Menkul Degerler AS

    • Language: English
    • 37 Pages
    • Published: April 2015
    FROM
  • Vontobel Holding AG - Product Thumbnail Image

    Vontobel Holding AG

    • Language: English
    • 38 Pages
    • Published: April 2015
    FROM

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.